References
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486–2497.
- Alberti KG, Zimmet P, Shaw J. The metabolic syndrome – a new worldwide definition. Lancet 2005;366:1059–1062.
- Lloyd-Jones D, Faha S, Adams R, Brown TM, Carnethon M, Dai S, De Simone G, Ferguson TB, Ford E, Furie K, Heart Disease and Stroke Statistics – 2010 update. A Report From the American Heart Association. Circulation 2010;121:e46–e215.
- Arnab G. Comparison of risk variables associated with the metabolic syndrome in pre- and postmenopausal Bengalee woman. Cardiovasc J Africa 2008;19:183–186.
- Cho GJ, Lee JH, Kim SH. Posmenopausal status according to years since menopause as an independent risk factor for the metabolic syndrome. Menopause 2008;15:524–529.
- Janssen I, Powell LH, Crawford S, Lasley B, Sutton Tyrrell K. Menopause and the metabolic syndrome. Arch Intern Med 2008;168:1568–1575.
- Collins P, Rosano G, Casey, Management of cardiovascular risk in the perimenopausical women: a consensus statement of European cardiologists and gynecologists. Climacteric 2007;10:508–526.
- Reaven G. The metabolic syndrome or the insulin resistance syndrome? Different names, different concepts and different goals. Endocrinol Metab Clin North Am 2004;33:283–303.
- Lawes CM, Vander Hoorn S, Law MR, Elliot P, MacMahon S. Blood pressure and the global burden of disease 2000. Estimates of blood pressure levels. J Hypertens 2006;24:413–422.
- Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension: an age old debate. Hypertension 2008;51:952–959.
- Taddei S. Blood pressure through aging and menopause. Climacteric 2009;12(Suppl. 1):36–40.
- Michio Otsuki MD, Soji Kasayama MD, Shinya Morita MD, Noboyuki Asanuma MD, Hiroshi Saito MD, Masafumi Koga MD. Menopause, but no age, is an independent risk factor for fasting plasma glucose levels in non diabetic women. Menopause: J North Am Menopause Soc 2007;14:404–407.
- Kanaya AM, Herrington D, Vittinghoff E. Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen/progestin Replacement Study. A randomized double- blind placebo controlled trial. Ann Intern Med 2003;138:1–9.
- Rita M, Tim S, Ramasamyiyer S, Harold S. Genetic and environmental influences on lipids, lipoproteins, and apolipoproteins. Effects of Menopause. Arterioscler Thromb Vasc Biol 2002;22:1142–1147.
- Rossouw JE, Prentice RL, Manson JE, Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465–1477.
- Rogerio L. Metabolic syndrome after menopause and the role of hormones. Maturitas 2008;60:10–18.
- Snieder H, Doornen LJP, Boomsma D. The age dependency of gene expression for plasma lipids, lipoproteins and apolipoproteins. Am J Hum Genet 1997;60:638–650.
- Nance WE, Bodurtha JN, Eaves LJ, Hewitt J, Maes H, Segrest J, Meyer J, Neale MC, Models for the longitudinal genetic analysis of same age twins: application to HDL cholesterol. Twin Res 1998;1:3–8.
- Pao-Ling T, Ta-Chen S, Fung C, Kuo-Liong C, Su-Cheng H, Song-Nan C, Yuan-The L. Effects of menopause on intraindividual changes in serum lipids, blood pressure, and body weight- the Chin-Shan community cardiovascular cohort study. Atherosclerosis 2002;161:409–415.
- Petri Nahas E, Padoani NP, Nahas-Neto J, Orssatti FL, Tardibo AP, Dias R. Metabolic syndrome and its associated risk factors in Brazilian postmenopausal women. Climateric 2009;12:431–438.
- Brown TD, Vaidya D, Rogers WJ, Waters D, Howard BV, Tardif JC, Bittwer V. Does prevalence of the metabolic syndrome in women with coronary artery disease differ by the ATP III and IDF criteria? J Women Health 2008;17:841–847.
- Ford ES. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 2005;28:2745–50.
- Gonzalez-Ortiz M, Martinez-Abundis E, Jacques-Camarena O, Hernandez-Gonzalez SO, Valera-Gonzalez IG, Ramos-Zavala MG. Prevalence of metabolic syndrome in adults with excess of adiposity: comparison of the Adult Treatment Panel III criteria with the International Diabetes Federation definition. Acta Diabetol 2006;43:84–90.
- Meigs JB, Rutter MK, Sullivan LM, Fox CS, DÁgostino RB, Wilson PW. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome. Diabetes Care 2007;30:1219–1225.
- Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a predictor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005;112:3066–3072.